Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Technology Process of Heplisav

Heplisav

Base Information
  • Chemical Name:Heplisav
  • CAS No.:104504-34-9
  • Molecular Formula:C135H199 N39 O38 S
  • Molecular Weight:3008.33
  • Hs Code.:
  • Mol file:104504-34-9.mol
Heplisav

Synonyms:Heplisav;104504-34-9;HEPATITIS B VIRUS PRE-S REGION (120-145);Glycine, L-methionyl-L-glutaminyl-L-tryptophyl-L-asparaginyl-L-seryl-L-threonyl-L-threonyl-L-phenylalanyl-L-histidyl-L-glutaminyl-L-threonyl-L-leucyl-L-glutaminyl-L-.alpha.-aspartyl-L-prolyl-L-arginyl-L-valyl-L-arginylglycyl-L-leucyl-L-tyrosyl-L-phenylalanyl-L-prolyl-L-alanylglycyl-

Suppliers and Price of Heplisav
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Biorbyt Ltd
  • Hepatitus B Virus Pre-S Region (120-145) > 95%
  • 1 mg
  • $ 598.40
  • Biorbyt Ltd
  • Hepatitus B Virus Pre-S Region (120-145) > 95%
  • 10 mg
  • $ 1900.60
  • Biorbyt Ltd
  • Hepatitus B Virus Pre-S Region (120-145) > 95%
  • 5 mg
  • $ 1271.60
  • American Custom Chemicals Corporation
  • HEPATITIS B VIRUS PRE-S REGION (120-145) 95.00%
  • 1MG
  • $ 802.73
  • American Custom Chemicals Corporation
  • HEPATITIS B VIRUS PRE-S REGION (120-145) 95.00%
  • 0.5MG
  • $ 676.50
Total 10 raw suppliers
Chemical Property of Heplisav
Chemical Property:
  • PSA：1277.62000 
  • LogP:1.62730 
  • Storage Temp.:−20°C 
  • XLogP3:-10.8
  • Hydrogen Bond Donor Count:41
  • Hydrogen Bond Acceptor Count:44
  • Rotatable Bond Count:95
  • Exact Mass:3007.4592491
  • Heavy Atom Count:213
  • Complexity:7120
Purity/Quality:

99%, *data from raw suppliers

Hepatitus B Virus Pre-S Region (120-145) > 95% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC2=CC=CC=C2)C(=O)N3CCCC3C(=O)NC(C)C(=O)NCC(=O)NCC(=O)OC(=O)C(C(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C4CCCN4C(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC5C=NC=N5)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)C(CCC(=O)N)NC(=O)C(CCSC)N)NC(=O)CNC(=O)C(CCCNC(=N)N)N
  • Isomeric SMILES:C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC5C=NC=N5)NC(=O)[C@H](CC6=CC=CC=C6)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC7=CNC8=CC=CC=C87)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCSC)N)O
  • Recent ClinicalTrials:Open-Label Study of the Safety and Immunogenicity of HEPLISAV? Hepatitis B Virus Vaccine
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 104504-34-9

Total 8 Pictures about this product